Anat Shirvan
No más puestos en curso
Historial de carrera de Anat Shirvan
Antiguos cargos conocidos de Anat Shirvan.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Director Técnico/Científico/I+D | 01/01/2010 | - |
APOSENSE LTD | Director/Miembro de la Junta | 09/10/1996 | - |
Director Técnico/Científico/I+D | 01/12/1997 | - | |
Fundador | 21/07/2009 | - |
Formación de Anat Shirvan.
The Hebrew University of Jerusalem | Doctorate Degree |
Estadísticas
Internacional
Israel | 4 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Founder | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Aposense Ltd.
Aposense Ltd. Pharmaceuticals: MajorHealth Technology Aposense Ltd. engages in the provision of proprietary conjugates. It offers platform technology which comprises the rational design of small molecular moieties with the increased affinity to the cell membranes imparting the conjugates compound with improved drug properties such as extended life span oral bioavailabity and selective at target site. The company was founded by Ilan Ziv and Jacob Gottenstein on October 9, 1996 and is headquartered in Petach-Tikva, Israel. | Health Technology |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Anat Shirvan
- Experiencia